HIV Trojan horse

Virxsys turns HIV's ability to infect cells against the virus in T cell vaccine

HIV's ability to hide out in the body in places that drugs can't reach has helped the virus remain resistant to eradication. But Virxsys Corp. thinks its VRX1273 may be able to provide a functional cure for some patients by reaching all the walls into these disease reservoirs.

The therapeutic

Read the full 493 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers